-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, J1n1DgKBT0CguwJBhik/d9byUM5MvP57j0QKSGsCBhDgrJ0sc8jeHG9EfPLKJm3c rYyAD2+2bUNWoBVqLdK37g== 0000077551-04-000088.txt : 20040806 0000077551-04-000088.hdr.sgml : 20040806 20040806092412 ACCESSION NUMBER: 0000077551-04-000088 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040804 FILED AS OF DATE: 20040806 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HUNKAPILLER MICHAEL W CENTRAL INDEX KEY: 0001216799 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-04389 FILM NUMBER: 04956279 MAIL ADDRESS: STREET 1: C/O APPLERA CORP STREET 2: 850 LINCOLN CENTRE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: APPLERA CORP CENTRAL INDEX KEY: 0000077551 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 061534213 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 301 MERRITT 7 CITY: NORWALK STATE: CT ZIP: 06851 BUSINESS PHONE: 2038402000 MAIL ADDRESS: STREET 1: 301 MERRITT 7 CITY: NORWALK STATE: CT ZIP: 06851 FORMER COMPANY: FORMER CONFORMED NAME: PE CORP DATE OF NAME CHANGE: 19990129 FORMER COMPANY: FORMER CONFORMED NAME: PERKIN ELMER CORP DATE OF NAME CHANGE: 19930601 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2004-08-04 0000077551 APPLERA CORP ABI/CRA 0001216799 HUNKAPILLER MICHAEL W APPLERA CORP - APPLIED BIOSYSTEMS GROUP 850 LINCOLN CENTRE DRIVE FOSTER CITY CA 94404 0 1 0 0 Senior Vice President Celera Genomics Group Common Stock 2004-08-04 4 S 0 60 11.57 D 142076.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 240 11.55 D 141836.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 480 11.54 D 141356.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 120 11.52 D 141236.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 120 11.50 D 141116.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 60 11.49 D 141056.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 180 11.48 D 140876.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 180 11.45 D 140696.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 168 11.44 D 140528.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 12 11.43 D 140516.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 180 11.41 D 140336.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 60 11.40 D 140276.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 180 11.38 D 140096.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 120 11.30 D 139976.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 360 11.22 D 139616.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 300 11.21 D 139316.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 300 11.20 D 139016.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 300 11.19 D 138716.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 420 11.18 D 138296.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 360 11.17 D 137936.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 120 11.16 D 137816.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 420 11.15 D 137396.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 120 11.13 D 137276.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 120 11.11 D 137156.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 240 11.10 D 136916.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 120 11.08 D 136796.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 300 11.07 D 136496.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 240 11.06 D 136256.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 60 11.04 D 136196.0325 D Celera Genomics Group Common Stock 2004-08-04 4 S 0 60 11.03 D 136136.0325 D Reflects transactions executed by an independent third-party administrator pursuant to a 10b5-1 trading program. 1 of 3 of Forms 4 filed on August 6, 2004 for Michael W. Hunkapiller Thomas P. Livingston, Attorney-in-Fact for Michael W. Hunkapiller 2004-08-06 -----END PRIVACY-ENHANCED MESSAGE-----